Warburg Pincus & Co.
CIK: 0000929408
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sotera Health Co
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 13, 2026SHC
Sotera Health Co
Sale(S)Indirect19.1M shares at avg. $15.17$289.8M - Mar 6, 2026SHC
Sotera Health Co
Sale(S)Indirect15M shares at avg. $15.27$229.1M - Dec 3, 2025SHC
Sotera Health Co
Sale(S)Indirect9.7M shares at avg. $16.33$158.7M - Nov 10, 2025SHC
Sotera Health Co
Sale(S)Indirect18M shares at avg. $15.65$281.7M - Sep 5, 2025SHC
Sotera Health Co
Sale(S)Indirect12M shares at avg. $15.11$181.3M - Sep 6, 2024SHC
Sotera Health Co
Sale(S)Indirect15M shares at avg. $15.03$225.4M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 13, 2026 | SHC Sotera Health Co | Sale(S) | 19,102,952 | $15.17 | $289,753,576 | Indirect |
| Mar 6, 2026 | SHC Sotera Health Co | Sale(S) | 15,000,000 | $15.27 | $229,050,000 | Indirect |
| Dec 3, 2025 | SHC Sotera Health Co | Sale(S) | 9,720,000 | $16.33 | $158,727,600 | Indirect |
| Nov 10, 2025 | SHC Sotera Health Co | Sale(S) | 18,000,000 | $15.65 | $281,718,000 | Indirect |
| Sep 5, 2025 | SHC Sotera Health Co | Sale(S) | 12,000,000 | $15.11 | $181,332,000 | Indirect |
| Sep 6, 2024 | SHC Sotera Health Co | Sale(S) | 15,000,000 | $15.03 | $225,450,000 | Indirect |
1-6 of 6 transactions
About WARBURG PINCUS & CO.
WARBURG PINCUS & CO. (SEC CIK 0000929408) files insider reports with the SEC as Director of Sotera Health Co (SHC).
Signal8 holds 12 ownership filings by WARBURG PINCUS & CO., all Form 4s, filed between Sep 9, 2024 and May 15, 2026. Those filings report 6 transactions, from Sep 6, 2024 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WARBURG PINCUS & CO.'s filings is in NY, NY.
Recent filings by WARBURG PINCUS & CO.
- May 13, 2026: Open-market sale of SHC shares (Form 4, code S).
- Mar 6, 2026: Open-market sale of SHC shares (Form 4, code S).
- Dec 3, 2025: Open-market sale of SHC shares (Form 4, code S).
- Nov 10, 2025: Open-market sale of SHC shares (Form 4, code S).
- Sep 5, 2025: Open-market sale of SHC shares (Form 4, code S).
Other insiders filing for Sotera Health Co (SHC)
- Petras Michael B. Jr., Executive Chairman
- Rutz Michael P, President of Sterigenics
- Lyons Jonathan M., Sr. Vice President, CFO
- Klee Ann R., Director
- SHADER ALTON, Chief Executive Officer
- Kyle Richard G, Director